Navigation Links
FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
Date:3/3/2008

BOSTON, March 3 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough cardiovascular molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I safety results for CardioPET, the company's lead product.

The trial was designed to evaluate safety, distribution and dosimetry of CardioPET as a PET tracer for myocardial imaging in healthy subjects and patients with Coronary Artery Disease (CAD). Dr. David Elmaleh, Chairman and scientific founder of FluoroPharma, presented findings from the Phase I trial at the "Clinical Trials Update" session at a Society of Nuclear Medicine conference in Denver, CO.

CardioPET is a novel metabolic cardiac PET imaging agent that allows assessment of acute and chronic coronary artery disease while patients are at rest. FluoroPharma anticipates that CardioPET may be an accurate alternative to standard treadmill stress-testing and for patients that are unable to exercise.

"The CardioPET trial achieved all safety endpoints and experienced no safety issues," said Alan J. Fischman, MD, PhD, Principal Investigator of the CardioPET study. "CardioPET performed well in both healthy volunteers and patients with CAD." Dr. Fischman is a Professor of Radiology at Harvard Medical School and the former Director of Nuclear Medicine at Massachusetts General Hospital.

H. William Strauss, MD, the trial's medical monitor, was also optimistic about CardioPET's potential. "The promise of utilizing PET imaging with a fatty acid analog such as CardioPET to assess integrity of the heart encompasses a wide range of potential indications, and we look forward to validating CardioPET's continued safety in Phase II clinical trials. The PET technology we are studying today shows early promise and may hold the key to better quality CAD diagnoses." Dr. Strauss is the Clinical Director of Nuclear Medicine at Memorial Sloan Kettering Cancer Center and Professor of Radiology at Corne
'/>"/>

SOURCE FluoroPharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a leading ... pharmaceutical, biotechnology, and medical device industries with operations in ... United States , congratulates our partner TaiMed Biologics ... for ibalizumab (TMB355). The FDA designates a drug as ... in combination with one or more other drugs, to ...
(Date:2/27/2015)... - La ... monitoraggio dell,infarto congestizio (CHF - Congestive Heart Failure) ...   Vectorious Medical Technologies, società ... il monitoraggio cardiaco destinato a pazienti affetti da ... concluso una raccolta di finanziamenti per 5 milioni ...
(Date:2/27/2015)... Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... Barclays 2015 Annual Healthcare Conference on March 10 in ... Dan Brennan , executive vice president and chief financial ... Relations, will participate in a 25-minute question and answer ... approximately 1:05 p.m. ET. Following a 5-minute break, a ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... joined the ranks of a select group.  The 41-bed provider ... one of only 100 hospitals to do so as of ... Health IT Policy Committee, an industry group that works with ... (ONC-HIT). The Jacksboro, Texas-based hospital is leveraging the ...
... 2011 Elekta announced it has received approval ... system in the European Union. Integrity R1.1 combines ... rate (CVDR) and interdigitation capabilities for Elekta,s MLCi2™ ... of delivery techniques -- such as Intensity Modulated ...
Cached Medicine Technology:Faith Community Hospital Joins Meaningful Use Trailblazers 2Faith Community Hospital Joins Meaningful Use Trailblazers 3New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 2New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 3
(Date:2/28/2015)... Portland, OR (PRWEB) February 28, 2015 ... Duncan Fletcher of Game Change ... and Shannon Leinert about the benefits of athlete development ... underscores some of the unique challenges that athletes face ... on-field and future success. , Fletcher became involved in ...
(Date:2/28/2015)... March—also known as National Brain ... ourselves and others that suspected head injuries, especially ... (ANS). , Concussions are a form of traumatic ... TBIs. There are 1.6-3.8 million sports-related concussions per ... it is a brain injury. Many athletes suffer ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... India Network Foundation, a ... insurance programs for visitors coming to the United States ... traveling to the United States are suffering from one ... pressure. These diseases are so common among the elderly ... medical conditions. There were 66.8 million cases of diabetes ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... announce that they have officially relaunched their website. The ... user-friendly, but it contains a new section about their ... to read the full biographies of each Friedman Dental ... of the website was designed to provide our patients ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2
... The Crossings, the Texas Hill Country spa retreat, just ... Day for each day booked. From March 8 ... three healthy gourmet meals, gracious and comfortable accommodations with beautiful ... day. In addition, The Crossings offers a heated infinity ...
... Versus Technology,Inc. ("Versus" or the "Company") (OTC Pink ... ended January 31, 2009, a 13% increase over,revenues of ... growth in revenue is,attributable, in part, to more than ... service revenues. Versus, quarterly revenues can vary,significantly depending ...
... listed No. 1 in Health Care: Pharmacy and Other Services ... management worldwideFRANKLIN LAKES, N.J., March 6 Medco Health Solutions, ... position within the Health Care: Pharmacy and Other Services sector ... In addition, of all companies surveyed globally, Medco was ranked ...
... minorities than whites meet criteria for cutting-edge treatment , , ... Hispanic Medicare recipients suffer severe heart failure, they are ... with the most cutting-edge treatment available, a new analysis ... modest differences between racial and ethnic groups in the ...
... Today World Lung Foundation and the American Cancer Society ... online version of the document at TobaccoAtlas.org. This comprehensive ... how tobacco is devastating both global health and economies. ... Economy , According to The Tobacco Atlas, tobacco,s ...
... release is available in German . , ... in the treatment of certain brain tumours. This has been ... German and Swiss colleagues in a current study. They treated ... The patients survived on average 23 months; with the standard ...
Cached Medicine News:Health News:A Massage A Day at The Crossings 2Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 2Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 3Health News:Blacks, Hispanics Less Apt to Get Best Heart Failure Care 2Health News:Blacks, Hispanics Less Apt to Get Best Heart Failure Care 3Health News:New edition of the Tobacco Atlas catalogues catastrophic toll of tobacco worldwide 2Health News:New edition of the Tobacco Atlas catalogues catastrophic toll of tobacco worldwide 3Health News:Brain tumors: New therapy surprisingly successful 2
The Restoration GAP system addresses complex acetabular reconstruction with morselized graft through immobilization and proper compressive loading, the two mechanical factors influencing the integrat...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Performa uncemented stem....
Porous foundation 480 series....
Medicine Products: